Disparities in Immunotherapy Cancer Care

To ensure more optimized use of immunotherapies, clinicians need to understand the ongoing barriers and implement tactics to best address disparities within their own practice amongst their diverse patient populations with cancer.


Follow real-world patients on their cancer journeys as they and their multidisciplinary clinical teams navigate barriers to receiving treatment with immunotherapy. Complementing these stories are insights from experts on the underlying issues fueling disparate access to immunotherapies as well as strategies to overcome treatment barriers for patients in under-resourced communities. Visit https://www.cancercaredisparities.org/ to learn more or claim CME.

Help close persistent immunotherapy access gaps to ensure your patients receive the best possible care.

Supported by an educational grant from Bristol-Myers Squibb.

Special thanks to: Carolyn Jones Productions, Thomas Jefferson University Hospital, and Einstein Medical Center Montgomery.